Author: Neuronetics

Posted Date:

June 2, 2026

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Neuronetics

June 2, 2026
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

Neuronetics

June 2, 2026
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

Neuronetics

May 14, 2026
Neuronetics Reports First Quarter 2026 Financial and Operating Results

Neuronetics

May 5, 2026
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics

April 29, 2026
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

Neuronetics

April 21, 2026
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

Neuronetics

April 13, 2026
Neuronetics Comments on Letter from Pointillist Family Office

Neuronetics

April 7, 2026
Neuronetics Announces Chief Financial Officer Transition

Neuronetics

April 6, 2026
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

Neuronetics

March 17, 2026